两种血液净化方法治疗尿毒症患者心包积液的对比观察
|
摘要
目的探讨2种血液净化方法对尿毒症患者心包积液的疗效。方法随机选取尿毒症伴心包积液患者208例,其中治疗组103例,采用连续性静-静脉血液滤过(CVVH)的方法。对照组105例采用血液透析疗法。超声心动图分别检测2组治疗前后的左心室后壁心包积液量,并进行比较。结果 2种血液净化方法治疗后心包积液量较治疗前均有显著改善(P<0.05),CVVH好于血液透析(P<0.05)。结论 CVVH较血液透析在治疗尿毒症患者心包积液中具优越性。
Objective To explore the effect of two kinds of blood purification treatment for pericardial effusion in patients with uremia.Methods We randomly selected 208 cases of uremia with pericardial effusion,of which 103 cases of treatment group,using continuous veno-venous hemofiltration(CVVH)therapy.The control group of 105 patients use hemodialysis therapy.Ultrasonic cardiogram is used to detect the pericardial effusion of left ventricular posterior wall before and after treatment in two groups.Results Pericardial effusion has both significantly improved(P<0.05)after two methods of blood purification treatment,and CVVH is better than hemodialysis(P<0.05).Conclusion CVVH has more advantages than hemodialysis in treating uremic patients with pericardial effusion.
Objective To explore the effect of two kinds of blood purification treatment for pericardial effusion in patients with uremia.Methods We randomly selected 208 cases of uremia with pericardial effusion,of which 103 cases of treatment group,using continuous veno-venous hemofiltration(CVVH)therapy.The control group of 105 patients use hemodialysis therapy.Ultrasonic cardiogram is used to detect the pericardial effusion of left ventricular posterior wall before and after treatment in two groups.Results Pericardial effusion has both significantly improved(P<0.05)after two methods of blood purification treatment,and CVVH is better than hemodialysis(P<0.05).Conclusion CVVH has more advantages than hemodialysis in treating uremic patients with pericardial effusion.
引文
[1]喻明书.15例大量心包积液临床诊治分析[J].中国卫生产业,2011,9(1):137.
[2]叶任高,李幼姬,刘冠贤.临床肾脏病学[M].2版.北京:人民卫生出版社,2007:556.
[3]尹连亮.左卡尼汀治疗尿毒症心脏病变64例临床观察[J].中外医疗,2010,29(4):106.
[4]郝峥,詹瑞英.血液透析滤过治疗透析后心包积液[J].临床荟萃,2007,22(23):封2.
[5]陈香梅.血液净化标准操作规程[M].北京:人民军医出版社,2010:51,83.
[6]Zahiti B,Bakalli A,Gorani D,et al.The importance of echocardiographic evaluation of pericardial effusion associated with mitral valve pseudoprolapse in patients with chronic renal failure[J].Saudi J Kidney Dis Transpl,2011,22(5):994-997.
[7]齐斌,任威,李春江,等.血管内皮生长因子和内皮抑素在恶性心包积液中的鉴别诊断价值[J].山西医药杂志,2013,42(11):1119-1120.
[8]李慧敏,王宗谦.慢性肾功能衰竭透析治疗患者并发浆膜腔积液的临床分析[J].山西医药杂志,2013,42(3):296-297.
[9]邱炽昌.血液透析个体化超滤治疗尿毒症合并大量心包积液临床探讨[J].实用临床医药杂志,2010,14(17):144-145.
[10]赖红玲.连续性血液净化治疗急性重症胰腺炎的发展前景[J].实用医技杂志,2008,14(24):3403-3404.
[11]陈媛媛,詹文红.连续性静-静脉血液滤过治疗多器官功能障碍综合征伴高血钾患者的护理[J].护理学杂志,2009,24(15):18-19.
[2]叶任高,李幼姬,刘冠贤.临床肾脏病学[M].2版.北京:人民卫生出版社,2007:556.
[3]尹连亮.左卡尼汀治疗尿毒症心脏病变64例临床观察[J].中外医疗,2010,29(4):106.
[4]郝峥,詹瑞英.血液透析滤过治疗透析后心包积液[J].临床荟萃,2007,22(23):封2.
[5]陈香梅.血液净化标准操作规程[M].北京:人民军医出版社,2010:51,83.
[6]Zahiti B,Bakalli A,Gorani D,et al.The importance of echocardiographic evaluation of pericardial effusion associated with mitral valve pseudoprolapse in patients with chronic renal failure[J].Saudi J Kidney Dis Transpl,2011,22(5):994-997.
[7]齐斌,任威,李春江,等.血管内皮生长因子和内皮抑素在恶性心包积液中的鉴别诊断价值[J].山西医药杂志,2013,42(11):1119-1120.
[8]李慧敏,王宗谦.慢性肾功能衰竭透析治疗患者并发浆膜腔积液的临床分析[J].山西医药杂志,2013,42(3):296-297.
[9]邱炽昌.血液透析个体化超滤治疗尿毒症合并大量心包积液临床探讨[J].实用临床医药杂志,2010,14(17):144-145.
[10]赖红玲.连续性血液净化治疗急性重症胰腺炎的发展前景[J].实用医技杂志,2008,14(24):3403-3404.
[11]陈媛媛,詹文红.连续性静-静脉血液滤过治疗多器官功能障碍综合征伴高血钾患者的护理[J].护理学杂志,2009,24(15):18-19.